The roundtable focused on the transformative potential of AI and (GenAI) in omni-channel engagement for healthcare professionals (HCPs). The discussion explored how AI reshapes interactions, drives personalized experiences, and enhances processes across clinical trials, marketing, and patient engagement.
Pfizer is leveraging AI to revolutionize drug development. AI is viewed as a game-changer, impacting every stage of the pharmaceutical process, from preclinical research to patient access and manufacturing, with both operational and transformative applications.
Servier has approached AI adoption in two phases. Initially, an opportunistic approach focused on proving AI's potential through specific use cases, especially in collaboration with R&D teams.
This roundtable at the AI for Health Summit 2024 focused on the use of health data and artificial intelligence to address diagnostic delays and impasses for rare diseases. With contributions from key players in research, healthcare, and industry, this discussion emphasized the need for collective mobilization to enhance the lives of over 3 million patients in France affected by rare diseases.
Read the synthesis of Artefact's report and discover insights from healthcare and pharma companies, like Servier, Pfizer, Johnson & Johnson, Google, Elaia, Inato, Klineo, Deemea, and Naaia.
With market data costs soaring—some firms reporting increases of up to 50%—controlling these expenses has become a strategic priority for financial services organizations.
Today’s businesses face the challenge of building personalised connections with customers across multiple channels. A Customer Engagement Platform (CEP) is designed to simplify this by centralising and streamlining customer interactions, creating consistency and fostering stronger relationships. By unifying data and facilitating real-time engagement, CEPs enable companies to deliver tailored, impactful experiences that build loyalty and drive growth.
In today's data-driven world, understanding the journey of data—from its origin to its final destination—is more crucial than ever. This capability, referred to as data lineage, provides a comprehensive view of how data flows through an organization, detailing its transformations and dependencies along the way.
The first documented live performance blending generative AI and a musician took place in November 2022, when pianist David Dolan (Guildhall School of Music and Drama) improvised in dialogue with a semi-autonomous AI system designed by composer Oded Ben-Tal (Kingston University). This groundbreaking concert demonstrated the creative possibilities of AI as a collaborative partner in music.
